Research Analysts’ Weekly Ratings Updates for Merck & Co., Inc. (MRK)

Several brokerages have updated their recommendations and price targets on shares of Merck & Co., Inc. (NYSE: MRK) in the last few weeks:

• 5/16/2026 – Merck & Co., Inc. was downgraded by Wall Street Zen from “buy” to “hold”.
• 5/15/2026 – Merck & Co., Inc. was downgraded by Weiss Ratings from “hold (c+)” to “hold (c)”.
• 5/6/2026 – Merck & Co., Inc. is now covered by Citigroup Inc.. They set a “neutral” rating and a $125.00 price target on the stock.
• 5/1/2026 – Merck & Co., Inc. had its “hold (c+)” rating reaffirmed by Weiss Ratings.
• 5/1/2026 – Merck & Co., Inc. had its price target lowered by Wells Fargo & Company from $150.00 to $145.00. They now have an “overweight” rating on the stock.
• 4/13/2026 – Merck & Co., Inc. had its price target raised by UBS Group AG from $130.00 to $145.00. They now have a “buy” rating on the stock.
• 4/6/2026 – Merck & Co., Inc. had its price target raised by JPMorgan Chase & Co. from $125.00 to $135.00. They now have an “overweight” rating on the stock.
• 3/30/2026 – Merck & Co., Inc. had its “outperform” rating reaffirmed by Royal Bank Of Canada. They now have a $142.00 price target on the stock.
• 3/28/2026 – Merck & Co., Inc. was upgraded by Wall Street Zen from “hold” to “buy”.
• 3/20/2026 – Merck & Co., Inc. had its price target raised by Citigroup Inc. from $120.00 to $125.00. They now have a “neutral” rating on the stock.

Merck & Co, Inc is a global biopharmaceutical company engaged in the discovery, development, manufacture and marketing of prescription medicines, vaccines, biologic therapies and animal health products. Its portfolio spans multiple therapeutic areas with a particular emphasis on oncology, vaccines and infectious disease, as well as therapies for metabolic and chronic conditions. Among its well-known products are the cancer immunotherapy Keytruda (pembrolizumab) and the human papillomavirus vaccine Gardasil; the company also markets a range of medicines and vaccines for veterinary use through Merck Animal Health.

Founded in the late 19th century as the U.S.